Occudo Quantitative Strategies LP Cue Biopharma, Inc. Transaction History

Occudo Quantitative Strategies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.77 - $3.09 $7,722 - $13,481	-4,363 Reduced 13.05%	29,076 $54,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.1 $57,515 - $103,660	33,439 New	33,439 $88,000
Q2 2023 Aug 14, 2023	BUY	$3.11 - $4.91 $76,583 - $120,908	24,625 Added 187.45%	37,762 $137,000
Q1 2023 May 15, 2023	SELL	$2.41 - $3.74 $3,660 - $5,681	-1,519 Reduced 10.36%	13,137 $46,000
Q4 2022 Feb 14, 2023	SELL	$2.39 - $3.95 $13,259 - $21,914	-5,548 Reduced 27.46%	14,656 $41,000
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $102,426 - $154,787	-45,931 Reduced 69.45%	20,204 $45,000
Q2 2022 Aug 15, 2022	BUY	$2.49 - $5.92 $30,325 - $72,099	12,179 Added 22.57%	66,135 $165,000
Q1 2022 May 16, 2022	BUY	$4.41 - $12.28 $237,945 - $662,579	53,956 New	53,956 $263,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.